目前,许多45岁以上的妇女只能凑合着用年轻女人的卵细胞进行体外受精。
Other treatments will become available sooner.
另一种疗法也将很快得到应用。
OvaScience, a fertility company based in Boston which has exclusive rights to exploit DrTillys research on mammalian ovarian stem cells, will begin offering a novel treatment inJuly.
波士顿的OvaScience公司独家开发Tilly博士的哺乳动物卵巢干细胞细胞研究。
This uses a womans own stem cells to provide her eggs with extra energy by creating freshmitochondriasub-units that exist within cells and supply them with energy.
今年7月,该公司将开始提供一种全新的疗法:使用卵巢干细胞制造线粒体,给妇女的卵细胞增添活力。
They too can become scarcer and less productive with age.
线粒体的数量和活力也会随着年龄增长而递减。
Previous studies have shown that boosting mitochondria can dramatically increase the successrates of IVF.
此前的研究表明,增加线粒体数量能极大提高体外受精的成功率。
When it comes to reproduction, men will still have it easier for some time.
谈起繁衍来,男人还能优哉游哉一阵子。
【2015考研英语阅读人类繁衍】相关文章:
最新
2016-10-18
2016-10-11
2016-10-11
2016-10-08
2016-09-30
2016-09-30